ATE109981T1 - Therapeutische mittel. - Google Patents

Therapeutische mittel.

Info

Publication number
ATE109981T1
ATE109981T1 AT90904349T AT90904349T ATE109981T1 AT E109981 T1 ATE109981 T1 AT E109981T1 AT 90904349 T AT90904349 T AT 90904349T AT 90904349 T AT90904349 T AT 90904349T AT E109981 T1 ATE109981 T1 AT E109981T1
Authority
AT
Austria
Prior art keywords
formula
compound
ace
inhibitor
methyl
Prior art date
Application number
AT90904349T
Other languages
English (en)
Inventor
Patrick Coleman O'connor
Charles Leon-Marie Defesche
Original Assignee
Boots Co Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boots Co Plc filed Critical Boots Co Plc
Application granted granted Critical
Publication of ATE109981T1 publication Critical patent/ATE109981T1/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Epidemiology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
AT90904349T 1989-03-15 1990-03-12 Therapeutische mittel. ATE109981T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US32421389A 1989-03-15 1989-03-15

Publications (1)

Publication Number Publication Date
ATE109981T1 true ATE109981T1 (de) 1994-09-15

Family

ID=23262607

Family Applications (1)

Application Number Title Priority Date Filing Date
AT90904349T ATE109981T1 (de) 1989-03-15 1990-03-12 Therapeutische mittel.

Country Status (13)

Country Link
EP (1) EP0527720B1 (de)
JP (1) JPH04503806A (de)
KR (1) KR920700642A (de)
AT (1) ATE109981T1 (de)
AU (1) AU640128B2 (de)
CA (1) CA2049980A1 (de)
DE (1) DE69011692T2 (de)
DK (1) DK0527720T3 (de)
ES (1) ES2057542T3 (de)
IE (1) IE65902B1 (de)
IL (1) IL93744A (de)
WO (1) WO1990010445A1 (de)
ZA (1) ZA901945B (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0651640A1 (de) * 1992-07-21 1995-05-10 Knoll AG Verwendung von 7 - Fluoro-1-Methyl-3-Methylsulphenyl-4-chinolon zur Behandlungvon Angina Pectoris

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3542794A1 (de) * 1985-12-04 1987-06-11 Bayer Ag Antihypertensives kombinationspraeparat

Also Published As

Publication number Publication date
IL93744A0 (en) 1990-12-23
KR920700642A (ko) 1992-08-10
DK0527720T3 (da) 1994-12-05
WO1990010445A1 (en) 1990-09-20
ES2057542T3 (es) 1994-10-16
IE900818L (en) 1990-09-15
JPH04503806A (ja) 1992-07-09
CA2049980A1 (en) 1990-09-16
IL93744A (en) 1995-06-29
AU5261690A (en) 1990-10-09
EP0527720B1 (de) 1994-08-17
AU640128B2 (en) 1993-08-19
IE65902B1 (en) 1995-11-29
ZA901945B (en) 1991-01-30
DE69011692T2 (de) 1994-12-01
DE69011692D1 (de) 1994-09-22
EP0527720A1 (de) 1993-02-24

Similar Documents

Publication Publication Date Title
GB2303629B (en) Hydroxamic acids and their use as metalloproteinase inhibitors
GEP20033131B (en) Azabicycloalkanes as CCR5 Modulators, Pharmaceutical Compositions Containing the Same and Their Use for Treatment and Prevention of Diseases Caused by CCR5 Activity
SE8804629D0 (sv) New therapeutically active compounds
RU94041223A (ru) Средство для лечения мотонейроновых заболеваний
MX171191B (es) Composiciones farmaceuticas de glipizida
NO306677B1 (no) Heterosykliske forbindelser, farmasöytiske preparater og anvendelse av en slik forbindelse til fremstilling av et medikament
AR006598A1 (es) "composiciones anti-fungosas, su uso en la manufactura de medicamentos y un procedimiento para su preparación"
BR9814498A (pt) Processo para o tratamento de obesidade em um humano necessitando de tal tratamento, composto, uso do mesmo, produto, e, composição farmacêutica
DK0736029T3 (da) Antikonvulsive pseudofructopyranosesulfamater
EG19302A (en) Compound with gastric acid inhibitory effect and process for its preparation
AR011437A1 (es) Composicion farmaceutica para el tratamiento de la migrana y el uso de la misma en la preparacion de un medicamento.
GEP19991872B (en) Novel Taxoids, Preparations Thereof, and Pharmaceutical Compositions Containing Same
RU94040865A (ru) Производные пептида и их терапевтически приемлемые соли, способ их получения, фармацевтическая и косметическая композиция с антивирусной активностью
NO305560B1 (no) Krystallinsk 3-(4-heksyloksy-1,2,5-tiadiazol-3-yl)-1,2,5,6-tetrahydro-1-metylpyridin-(+)-L-hydrogentartrat, farmas°ytiske preparater som omfatter forbindelsen, samt anvendelse av forbindelsen til fremstilling av et medikament
ATE109981T1 (de) Therapeutische mittel.
EP1027051A4 (de) Antithrombotische mittel
GB1351437A (en) N-substituted amino acids having antiviral anti-inflammatory or anti-tumour activity
GB1375806A (de)
FI965153A0 (fi) Metalloproteinaasi-inhibiittorit
GEP20012366B (en) Thienyl-, Furil-, Pyrrolyl- and Biphenyl-Sulfonamides, Their Derivatives, Their Use in Medicinal Purposes, Pharmaceutical Composition Containing the Same and Method for Treatment
JO1664B1 (en) The compound has the effect of immobilizing gastric acid and the process of preparing it

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee